Johnson & Johnson Announces Five Initiatives to Help Find the ‘Missing Millions’ of Undiagnosed People Living with Tuberculosis.
Leveraging Cross-Sector Capabilities to Detect Cases of Adult TB.
Even before the emergence of COVID-19, less than half of the approximately 500,000 new cases of DR-TB each year were properly diagnosed. By collaborating with national governments, not-for-profit organizations and other members of the private sector, Johnson & Johnson is helping to bring care to these people and protect the vulnerable communities in which many of them live.

Project inSight is a new collaboration between Johnson & Johnson and the Global Fund in Indonesia and the Philippines that will further understanding of why it can be difficult to identify DR-TB patients. By combining the Global Fund’s scale and reach and Johnson & Johnson’s unique expertise in consumer and patient insights, new strategies can be devised to amplify efforts to identify, engage and support people living with DR-TB, particularly in the context of the COVID-19 pandemic.

“The ongoing innovation in TB services is not limited to tech-entrepreneurs. New collaborations, like Project inSight, are leveraging the unique strengths of the private sector and not-for-profits. Project inSight aims to find undiagnosed TB patients in Indonesia and the Philippines using the reach of the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and Johnson & Johnson’s expertise in consumer behaviour and human-centric design to identify, engage and support people living with DR-TB.”

Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson
World Economic Forum